Biomarkers of nanomaterials hazard from multi-layer data.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 07 2022
Historique:
received: 13 04 2022
accepted: 17 06 2022
entrez: 1 7 2022
pubmed: 2 7 2022
medline: 8 7 2022
Statut: epublish

Résumé

There is an urgent need to apply effective, data-driven approaches to reliably predict engineered nanomaterial (ENM) toxicity. Here we introduce a predictive computational framework based on the molecular and phenotypic effects of a large panel of ENMs across multiple in vitro and in vivo models. Our methodology allows for the grouping of ENMs based on multi-omics approaches combined with robust toxicity tests. Importantly, we identify mRNA-based toxicity markers and extensively replicate them in multiple independent datasets. We find that models based on combinations of omics-derived features and material intrinsic properties display significantly improved predictive accuracy as compared to physicochemical properties alone.

Identifiants

pubmed: 35778420
doi: 10.1038/s41467-022-31609-5
pii: 10.1038/s41467-022-31609-5
pmc: PMC9249793
doi:

Substances chimiques

Biomarkers 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3798

Informations de copyright

© 2022. The Author(s).

Références

Toxicol Sci. 2007 Jan;95(1):5-12
pubmed: 16963515
Inhal Toxicol. 2007 Aug;19(10):849-56
pubmed: 17687716
BMC Bioinformatics. 2007 Sep 03;8:328
pubmed: 17767709
Part Fibre Toxicol. 2009 Apr 30;6:14
pubmed: 19405955
Mol Med Rep. 2021 Mar;23(3):
pubmed: 33495816
Nanotoxicology. 2016 Aug;10(6):794-806
pubmed: 26674712
Toxicol Sci. 2007 May;97(1):163-80
pubmed: 17301066
Science. 2017 Mar 10;355(6329):1016-1018
pubmed: 28280165
Nat Nanotechnol. 2009 Nov;4(11):747-51
pubmed: 19893520
Appl In Vitro Toxicol. 2018 Dec 1;4(4):305-316
pubmed: 31890748
ACS Nano. 2014 Jun 24;8(6):5585-99
pubmed: 24847914
Small. 2020 May;16(21):e1907686
pubmed: 32227449
Crit Rev Toxicol. 2017 Jan;47(1):1-58
pubmed: 27537422
Science. 2015 Oct 23;350(6259):388-9
pubmed: 26494749
Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8483-8492
pubmed: 32894569
N Engl J Med. 2008 Apr 17;358(16):1682-91
pubmed: 18403759
Nanotoxicology. 2017 Aug;11(6):809-826
pubmed: 28816564
Nanotoxicology. 2014 Aug;8(5):533-48
pubmed: 23659652
Nat Methods. 2014 Mar;11(3):333-7
pubmed: 24464287
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7387-92
pubmed: 18492802
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3490-5
pubmed: 24550482
Mol Ther Nucleic Acids. 2019 Dec 6;18:363-374
pubmed: 31634682
Curr Opin Toxicol. 2017 Feb;2:109-119
pubmed: 28971163
J Mol Med (Berl). 2017 Nov;95(11):1191-1202
pubmed: 28864835
Toxicol Sci. 2010 Feb;113(2):422-33
pubmed: 19875681
Eur Respir J. 2011 Oct;38(4):761-9
pubmed: 21540304
NanoImpact. 2018 Jul;11:99-108
pubmed: 32140619
Science. 2004 Jun 11;304(5677):1678-82
pubmed: 15192232
Nat Nanotechnol. 2018 Jul;13(7):537-543
pubmed: 29980781
Adv Exp Med Biol. 2017;947:143-171
pubmed: 28168668
Sci Rep. 2016 Jun 02;6:25696
pubmed: 27254731
Front Genet. 2018 Oct 15;9:471
pubmed: 30374364
Nat Med. 2016 Aug;22(8):861-8
pubmed: 27376578
J Clin Invest. 2008 Feb;118(2):640-50
pubmed: 18172554
Nanotoxicology. 2013 Mar;7(2):144-56
pubmed: 22263934
Nanomaterials (Basel). 2020 Apr 08;10(4):
pubmed: 32276469
Drug Discov Today. 2013 Aug;18(15-16):716-23
pubmed: 23732176
ACS Nano. 2010 Aug 24;4(8):4872-8
pubmed: 20669976
Bioinformatics. 2020 Jun 1;36(11):3393-3400
pubmed: 32119073
ACS Nano. 2016 Jan 26;10(1):524-38
pubmed: 26700264
Adv Sci (Weinh). 2020 Oct 11;7(22):2002221
pubmed: 33240770
Toxicology. 2007 Jan 25;230(1):90-104
pubmed: 17196727
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Sep;10(5):e1513
pubmed: 29473695
Toxicol Sci. 2006 Jul;92(1):174-85
pubmed: 16613837
ACS Nano. 2017 Apr 25;11(4):3597-3613
pubmed: 28345861
ACS Nano. 2017 Apr 25;11(4):3786-3796
pubmed: 28380293
Part Fibre Toxicol. 2016 May 11;13(1):25
pubmed: 27169501
ACS Nano. 2015 Jan 27;9(1):146-63
pubmed: 25530437
Angew Chem Int Ed Engl. 2011 Feb 7;50(6):1260-78
pubmed: 21290492
Toxicol Appl Pharmacol. 2008 Sep 1;231(2):235-40
pubmed: 18534653

Auteurs

Vittorio Fortino (V)

Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.

Pia Anneli Sofia Kinaret (PAS)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
BioMediTech Institute, Tampere University, Tampere, Finland.
Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.

Michele Fratello (M)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
BioMediTech Institute, Tampere University, Tampere, Finland.
Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.

Angela Serra (A)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
BioMediTech Institute, Tampere University, Tampere, Finland.
Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.

Laura Aliisa Saarimäki (LA)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
BioMediTech Institute, Tampere University, Tampere, Finland.
Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland.

Audrey Gallud (A)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Govind Gupta (G)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Gerard Vales (G)

Finnish Institute of Occupational Health, Helsinki, Finland.

Manuel Correia (M)

National Food Institute, Technical University of Denmark, Kgs. Lynby, Denmark.

Omid Rasool (O)

Turku Bioscience Centre, University of Turku, and Åbo Akademi University, Turku, Finland.

Jimmy Ytterberg (J)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Marco Monopoli (M)

Department of Pharmaceutical and Medicinal Chemistry, Royal College of Surgeons in Ireland, Dublin, Ireland.

Tiina Skoog (T)

Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.

Peter Ritchie (P)

Institute of Occupational Medicine, Edinburgh, UK.

Sergio Moya (S)

Soft Matter Nanotechnology Laboratory, CIC biomaGUNE, San Sebastian, Spain.

Socorro Vázquez-Campos (S)

Leitat Technological Center, Terrassa, Spain.

Richard Handy (R)

School of Biological and Marine Sciences, University of Plymouth, Plymouth, UK.

Roland Grafström (R)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Division of Toxicology, Misvik Biology, Turku, Finland.

Lang Tran (L)

Institute of Occupational Medicine, Edinburgh, UK.

Roman Zubarev (R)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Riitta Lahesmaa (R)

Turku Bioscience Centre, University of Turku, and Åbo Akademi University, Turku, Finland.

Kenneth Dawson (K)

Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Dublin, Ireland.

Katrin Loeschner (K)

National Food Institute, Technical University of Denmark, Kgs. Lynby, Denmark.

Erik Husfeldt Larsen (EH)

National Food Institute, Technical University of Denmark, Kgs. Lynby, Denmark.

Fritz Krombach (F)

Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.

Hannu Norppa (H)

Finnish Institute of Occupational Health, Helsinki, Finland.

Juha Kere (J)

Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.

Kai Savolainen (K)

Finnish Institute of Occupational Health, Helsinki, Finland.

Harri Alenius (H)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.

Bengt Fadeel (B)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Dario Greco (D)

Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. dario.greco@tuni.fi.
BioMediTech Institute, Tampere University, Tampere, Finland. dario.greco@tuni.fi.
Institute of Biotechnology, University of Helsinki, Helsinki, Finland. dario.greco@tuni.fi.
Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere, Finland. dario.greco@tuni.fi.

Articles similaires

C-Reactive Protein Humans Biomarkers Inflammation
Humans Endoribonucleases RNA, Messenger RNA Caps Gene Expression Regulation
Arabidopsis Arabidopsis Proteins Osmotic Pressure Cytoplasm RNA, Messenger
Humans Retrospective Studies Male Critical Illness Female

Classifications MeSH